MAKE SURE YOUR DENTIST IS AN ADA MEMBER!: ADA Members Adhere to Strict Code of Ethics and Conduct. You should make sure you are SEEING AN ADA MEMBER DENTIST! Visit ADA Find-A-Dentist to Find One Near YOU
Ninth District Headquarters Office - Hawthorne, NY

2025 Ninth District President

Dr. Renuka Bijoor

ADA Update: a new login experience

We’re updating how you log in to your NYSDA and ADA account.

RENEW YOUR MEMBERSHIP TODAY!

3 EASY WAYS TO PAY 1 ONLINE: nysdental.org/renew 2 MAIL: Return dues stub and payment 3 PHONE: 1-800-255-2100

Member Assistance Program (MAP)

Life comes with challenges, but your new Member Assistance Program (MAP) is here to help. This free, confidential benefit is available to you and your household, offering resources and services to support mental health, reduce stress, and make life easier.

Welcome to the Ninth District Dental Association

The Ninth District Dental Society was formed in 1909 and renamed to the Ninth District Dental Association in 2002. We have a membership of over 1500 dentists in 5 counties: Westchester, Rockland, Dutchess, Orange and Putnam.

In its quest to serve both the public and the profession, the Ninth District embodies the highest ideals.

The mission of the 9th District Dental Association is to serve and support its members and the public by improving the oral health of our community through Advocacy, Continuing Education and Camaraderie.



The Ninth District Dental Association, in Partnership with the New York State Dental Foundation (NYSDF), will be hosting an

Oral Health Screening Event 
with the Hudson Valley Renegades and
Sponsored by Henry Schein Cares Foundation

September 5, 2025
6:00 pm - 9:00 pm

 

* * * * * * * * * * 

Don't Miss the 9th District Dental Association's General Meeting
Wednesday, September 17, 2025

The Westchester Manor
140 Saw Mill River Road
      Hastings-on-Hudson, NY
 

Register

Mahnaz Fatahzadeh, D.M.D., M.S.D.
Completed her Oral Medicine fellowship and MSD degree at the Rutgers School of Dental Medicine where she holds a faculty appointment as a professor of Oral Medicine and as an attending at the University hospital. Dr. Fatahzadeh is a diplomat of American Board of Oral Medicine and director of pre and post-doctoral oral medicine training and Oral Mucosal Diseases Clinic at the Rutgers School of Dental Medicine.

"Orofacial Manifestations of Systemic Diseases"

Course Objectives

Oral cavity is readily accessible for inspection and a gateway for assessment of general health. In fact, many systemic conditions affecting organs far from the head and neck region could manifest in the orofacial region, sometimes prior to their diagnosis. Abnormalities detected in the orofacial region may also represent complications related to medical therapy or raise concerns about substance abuse. This program provides illustrative examples of orofacial findings associated with diagnosed or subjectively silent systemic disease, medical therapy and substance abuse. Relevant signs, symptoms, and diagnostics are reviewed and the potential role of oral health care providers in recognition, referral, follow-up and overall management is emphasized.

Meeting Exhibitors (so far):  (company names are links to their websites)

 After Hours Cleaning

Altfest Personal Wealth Management

BonaDent Dental Labs

DDSMatch

Epstein Practice Brokerage

Garfield Refining Company

General Refining

Komet

M&T Bank

MLMIC Insurance Company

Orion Dental Solutions

Singular Anesthesia Services


Latest News Around the Tripartite

FDA Issues Final Guidance on Medical/Dental Device Shortages

Jan 6, 2025

Per the notice below, the United States Food and Drug Administration (FDA) has issued final guidance on notification of medical/dental device shortages.

FDA Issues Final Guidance on Notification of Device Discontinuance or Interruption Under Section 506J

Today, the U.S. Food and Drug Administration (FDA) issued this final guidance: Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act.  Under section 506J of the FD&C Act, manufacturers are required to notify the FDA, during or in advance of a public health emergency (PHE), of a permanent discontinuance or interruption in the manufacturing of certain devices that is likely to lead to a meaningful disruption in supply of that device in the United States.  This guidance provides information about notifications under section 506J during or in advance of any public health emergency.

Facts about the final guidance

This final guidance:

  • Helps manufacturers provide timely, informative notifications to prevent or mitigate device shortages.
  • Provides the 506J Device List, which specifies devices, by FDA product code, for which a manufacturer of such devices is required to notify the FDA in accordance with section 506J.
  • Clarifies that the FDA may receive additional voluntary notifications about medical device supply chain issues at any time, unrelated to the declaration or potential declaration of a PHE.

Upcoming Webinar on this guidance

On Tuesday, March 4, 2025, the FDA will host a webinar for those interested in learning more about the guidance.

Questions?

If you have questions about this final guidance, contact the Division of Industry and Consumer Education.


Latest News Around the Ninth


Around the Ninth District